Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tempest Therapeutics, Inc. | 24,000 | reported | 17 Mar 2021 | tx 9+1,232,018 |
| Metacrine, Inc. | 16,500 | reported | 18 May 2022 | tx 3+66,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2022 | GRANT_AWARD | Metacrine, Inc. | 16,500 | 0.00 USD | deriv |
| 24 May 2021 | GRANT_AWARD | Metacrine, Inc. | 16,500 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Metacrine, Inc. | 33,000 | 0.00 USD | deriv |
| 17 Mar 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 25 May 2020 | GRANT_AWARD | Tempest Therapeutics, Inc. | 282,000 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | Tempest Therapeutics, Inc. | 215,000 | 0.00 USD | deriv |
| 20 Jun 2019 | GRANT_AWARD | Tempest Therapeutics, Inc. | 76,007 | 0.00 USD | deriv |
| 15 Jan 2019 | GRANT_AWARD | Tempest Therapeutics, Inc. | 173,993 | 0.00 USD | deriv |
| 07 Dec 2018 | GRANT_AWARD | Tempest Therapeutics, Inc. | 74,400 | — | |
| 07 Dec 2018 | GRANT_AWARD | Tempest Therapeutics, Inc. | 174,839 | — | deriv |
| 07 Dec 2018 | GRANT_AWARD | Tempest Therapeutics, Inc. | 60,179 | — | deriv |
| 07 Dec 2018 | GRANT_AWARD | Tempest Therapeutics, Inc. | 151,600 | — | deriv |